Viewing Study NCT03556358


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2025-12-25 @ 9:55 PM
Study NCT ID: NCT03556358
Status: COMPLETED
Last Update Posted: 2022-01-14
First Post: 2018-06-01
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
Sponsor: Tanvex BioPharma USA, Inc.
Organization: